Akero Therapeutics, Inc. AKRO was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a ...

Akero Therapeutics (AKRO) shares have delivered sizable gains for investors over the past year, with the stock up roughly 72%. Lately, its performance has piqued interest because of strong month and ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Akero Therapeutics, Inc. (AKRO) is a stock that can certainly ...

The average one-year price target for Akero Therapeutics (NASDAQ:AKRO) has been revised to 74.46 / share. This is an increase of 16.10% from the prior estimate of 64.13 dated August 31, 2023. The ...

Akero Therapeutics (AKRO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.

Akero Therapeutics, Inc. (AKRO) closed the last trading session at $48.12, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...